Stereotaxis, Inc. (STXS)
2.32
-0.06
(-2.52%)
USD |
NYAM |
Dec 17, 14:22
Stereotaxis Research and Development Expense (Annual): 9.76M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Electromed, Inc. | 0.996M |
| IRIDEX Corp. | 5.179M |
| Axogen, Inc. | 27.77M |
| Phibro Animal Health Corp. | 23.73M |
| Myomo, Inc. | 4.772M |